Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging

Yuting Jessy Tan1, Travis E Conley1, Fuwen Yao1

  • 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.

Science (New York, N.Y.)
|July 16, 2026
PubMed

Insights

Aging impairs tissue repair by affecting tissue-resident macrophages (TRMs). Targeting the EP2 receptor on TRMs can restore youthful function and prevent age-related organ decline.

Area of Science:

  • Immunology
  • Aging research
  • Cellular biology

Background:

  • Aging disrupts tissue homeostasis and organ function.
  • Tissue-resident macrophages (TRMs) play a role in age-related decline.
  • Impaired clearance of senescent neutrophils contributes to aging.
  • Prostaglandin E2 (PGE2) receptor EP2 signaling is implicated in this process.

Purpose of the Study:

  • To investigate the role of TRM EP2 signaling in age-related organ decline.
  • To determine if modulating TRM EP2 signaling can reverse aging phenotypes.

Main Methods:

  • Studied aged mice with reduced TRM EP2 signaling.
  • Analyzed neutrophil efferocytosis and mitochondrial fitness.
  • Utilized plasma proteomics to identify liver involvement.
  • Examined aged and diseased human tissues for EP2 expression and senescent neutrophils.
  • Tested pharmacologic EP2 inhibition.

Main Results:

  • Reducing TRM EP2 signaling in aged mice preserved mitochondrial fitness and prevented multiple age-related conditions.
  • This intervention improved neutrophil efferocytosis and reduced cellular stress in the liver.
  • Elevated TRM EP2 expression and senescent neutrophils were found in aged human tissues.
  • Pharmacologic EP2 inhibition restored youthful neutrophil clearance.

Conclusions:

  • Impaired TRM efferocytosis of senescent neutrophils, driven by EP2 signaling, is a reversible cause of organ decline in aging.
  • Targeting TRM EP2 signaling offers a potential therapeutic strategy for age-related diseases.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammation01:38

Inflammation

Overview
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.